TotalMarketCap

Evaxion A/S

EVAXNasdaq DenmarkHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$25.547 M

$2.77 -6.73%

Close of 6 Nov 2026

As of 6 Nov 2026, Evaxion A/S (EVAX) has a market capitalization of $25.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

417,010,756

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #134Aligos TherapeuticsALGS$28.6M
  2. #135Metagenomi TherapeuticsMGX$27.7M
  3. #136Evaxion A/SEVAX$25.5M
  4. #137Cel SciCVM$24.6M
  5. #138BioStem TechnologiesBSEM$19.4M

What if Evaxion A/S were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,061,677

Per share 1,105,299× higher

Bitcoin $1.53T

$165,662.03

Per share 59,806× higher

Apple $5.02T

$543,853.00

Per share 196,337× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Evaxion A/S are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.